Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
about
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaisePsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorNanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitorsInterferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO).Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccinesIndoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012).The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities.Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure.Enantiomeric Separation of Monosubstituted Tryptophan Derivatives and Metabolites by HPLC with a Cinchona Alkaloid-Based Zwitterionic Chiral Stationary Phase and Its Application to the Evaluation of the Optical Purity of Synthesized 6-Chloro-l-TryptTargeting Leukemia Stem Cells in the Bone Marrow Niche.Immunotolerant indoleamine-2,3-dioxygenase is increased in condyloma acuminata.Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation.
P2860
Q27001628-323ED2C7-2334-4C47-A720-997CCB0E3D2CQ27694728-17B0E90D-F66B-4932-9992-1CF6284C9888Q28818166-3199BC47-5E4C-47F2-9794-E8E085A10903Q33832055-156C0834-F05D-49EC-9F04-E240CDD7AFDBQ34222959-57A0CD30-0662-460F-89B2-443CFA36A7A6Q34546698-1F3AA019-EB33-46E3-8E28-DB91CC49E8CBQ37089253-D0D2AC69-7489-4526-8331-A77D79DFD96AQ37137360-FC29EDD6-ADD7-4A7A-B3C7-1EAC3FF60CC9Q38132933-0A592B09-8552-4843-930D-5EE881AD83C7Q38356502-3C8B3B95-A569-4592-8130-388FDE9F9E55Q38675915-9D93143E-D64D-4ACC-959A-6ED234858445Q40816321-F4A7F653-4A52-4A58-9928-07A8DC10A3F8Q43095899-485CA996-D386-41A2-A40B-4DD1F56A09DBQ52375473-26CC78F4-2392-4B1E-AFE0-3EDAEDC021BDQ52797663-29F7B617-A41A-42BB-8C91-3575F10D2227Q53292207-C4C6C0F5-50BC-4937-8922-09F6373C6BF2
P2860
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@ast
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@en
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@nl
type
label
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@ast
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@en
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@nl
prefLabel
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@ast
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@en
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
@nl
P2860
P1476
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
@en
P2093
Silvio Danese
Tiziana Di Pucchio
P2860
P304
P356
10.1517/13543770903512974
P407
P577
2010-02-01T00:00:00Z